Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Bright Minds Biosciences (DRUG) Technical Analysis

300 Followers

Technical Sentiment

Overall Consensus
Strong SellStrong Buy
Sell
13Bearish
4Neutral
5Bullish
Technical Analysis Consensus
Strong SellStrong Buy
Buy
2Bearish
4Neutral
4Bullish
Moving Average Consensus
Strong SellStrong Buy
Strong Sell
11Bearish
0Neutral
1Bullish
Try our new Technical Analysis Screener >

1 Day timeframe · Data as of Nov 13, 2026

  • Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is -8.91, suggesting Bright Minds Biosciences is a Buy.
  • Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 34.21, while Bright Minds Biosciences’s (DRUG) share price is $23.11, making it a Sell.
  • Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 46.66, while Bright Minds Biosciences’s (DRUG) share price is $23.11, making it a Sell.
Advanced Chart >

Bright Minds Biosciences (DRUG) Pivot Points

1 Day timeframe · Data as of Nov 13, 2026

DRUG pivot points
NameS3S2S1Pivot PointsR1R2R3
Classic19.9921.0421.8922.9423.7924.8425.69
Fibonacci21.0421.7722.2122.9423.6724.1124.84

Bright Minds Biosciences (DRUG) Moving Averages

1 Day timeframe · Data as of Nov 13, 2026

DRUG moving averages
PeriodSimpleExponential
MA523.20Sell23.49Sell
MA1022.64Buy26.99Sell
MA2038.16Sell34.21Sell
MA5048.92Sell46.66Sell
MA10061.68Sell56.71Sell
MA20070.11Sell65.79Sell
  • Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 26.99, while Bright Minds Biosciences’s (DRUG) share price is $23.11, making it a Sell.
  • Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 56.71, while Bright Minds Biosciences’s (DRUG) share price is $23.11, making it a Sell.
  • Bright Minds Biosciences’s (DRUG) stock price is $23.11 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 48.92, creating a Sell signal.
  • Bright Minds Biosciences’s (DRUG) stock price is $23.11 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 61.68, creating a Sell signal.
  • Bright Minds Biosciences’s (DRUG) stock price is $23.11 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 70.11, creating a Sell signal.

Bright Minds Biosciences (DRUG) Technical Indicators

1 Day timeframe · Data as of Nov 13, 2026

DRUG technical indicators
NameValueImplied Action
RSI (14)28.64Buy
STOCH (9,6)39.79Neutral
STOCHRSI (14)14.11Buy
MACD (12,26)-8.91Buy
ADX (14)41.37Neutral
Williams %R-85.86Buy
CCI (14)-64.61Neutral
ATR (14)4.37-
Ultimate Oscillator54.02Neutral
ROC-54.77Sell
  • Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 28.64, creating a Buy signal.
  • Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 41.37, creating a Neutral signal.
  • Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is -64.61, creating a Neutral signal.
  • Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is -54.77, creating a Sell signal.
Technical Analysis Screener >
Technical Analysis Screener.Customize your technical analysis to fit your
unique trading strategy with a flexible screenerTry it Now!

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators on the 1-day timeframe as of Nov 13, 2026, DRUG is a Sell.
What is DRUG’s RSI (14)?
DRUG’s RSI (14) is 28.64, which suggests DRUG is a Buy.
What is DRUG’s MACD?
DRUG’s MACD is -8.91, which suggests DRUG is a Buy.
What is DRUG’s 5-day moving average?
DRUG’s 5-day moving average is 23.20, which suggests DRUG is a Sell.
What is DRUG’s 20-day moving average?
DRUG 20-day moving average is 38.16, which suggests DRUG is a Sell.
What is DRUG’s 50-day moving average?
DRUG’s 50-day moving average is 48.92, which suggests DRUG is a Sell.
What is DRUG’s 200-day moving average?
DRUG’s 200-day moving average is 70.11, which suggests DRUG is a Sell.
What is DRUG’s Williams % R (14)?
DRUG’s Williams % R (14) is -85.86, which suggests DRUG is a Buy.
What is DRUG’s CCI (14)?
DRUG’s CCI (14) is -64.61, which suggests DRUG is a Neutral.